Skip to main content
. Author manuscript; available in PMC: 2008 Jun 1.
Published in final edited form as: Gastroenterology. 2007 Apr 13;132(7):2422–2437. doi: 10.1053/j.gastro.2007.03.101

Table 3.

Histologic Score for TxA-Induced Enteritis in Mice Pretreated With Protease Inhibitors

Pretreatment + treatment Epithelial damage Edema congestion Polymorphonuclear leukocyte infiltration Total score
Vehicle + vehicle control 0.44 ± 0.1 0.97 ± 0.1 1.29 ± 0.2 2.73 ± 0.4
Vehicle + TxA 1.61 ± 0.1a 1.77 ± 0.1a 1.90 ± 0.1 5.21 ± 0.2a
FUT-175 + vehicle control 1.02 ± 0.1 0.02 ± 0.1 0.88 ± 0.1 2.65 ± 0.2
FUT-175 + TxA 1.03 ± 0.2a 1.51 ± 0.2 1.77 ± 0.2 4.35 ± 0.3a
MPI-0442352 + vehicle control 0.56 ± 0.1 0.48 ± 0.02 0.56 ± 0.1 1.60 ± 0.2
MPI-0442352 + TxA 1.67 ± 0.2 1.93 ± 0.2 1.98 ± 0.2 5.55 ± 0.5
10 mg SBTI + vehicle control 0.30 ± 0.1 1.30 ± 0.1 1.46 ± 0.1 3.07 ± 0.2
10 mg SBTI + TxA 0.53 ± 0.1b 1.17 ± 0.3b 1.63 ± 0.1 3.32 ± 0.3b
20 mg SBTI + vehicle control 0.43 ± 0.1 0.56 ± 0.1 0.79 ± 0.1 1.87 ± 0.2
20 mg SBTI + TxA 0.86 ± 0.1b 1.06 ± 0.1b 1.24 ± 0.1 3.13 ± 0.3b

NOTE. Vehicle refers to vehicle for protease inhibitors, and vehicle control refers to vehicle for TxA.

a

P < .05 compared with inhibitor vehicle + vehicle control group.

b

P < .05 compared with inhibitor vehicle + TxA group.